Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 14,714,000 | 12,976,000 | 9,422,000 | 5,796,000 | 15,119,000 |
| Depreciation Amortization | 7,231,000 | 5,291,000 | 3,473,000 | 1,747,000 | 7,009,000 |
| Income taxes - deferred | -1,141,000 | -238,000 | -428,000 | 54,000 | -2,476,000 |
| Accounts receivable | 837,000 | -366,000 | -403,000 | -790,000 | -309,000 |
| Other Working Capital | 2,753,000 | -2,671,000 | -5,236,000 | -3,530,000 | 3,845,000 |
| Other Operating Activity | -858,000 | 201,000 | -18,000 | 81,000 | 228,000 |
| Operating Cash Flow | $23,536,000 | $15,193,000 | $6,810,000 | $3,358,000 | $23,416,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,042,000 | -1,924,000 | -1,200,000 | -608,000 | -233,000 |
| Net Acquisitions | -7,323,000 | -949,000 | -949,000 | -939,000 | -5,810,000 |
| Purchase Of Investment | -21,089,000 | -16,243,000 | -8,551,000 | -2,064,000 | -3,920,000 |
| Sale Of Investment | 12,137,000 | 6,585,000 | 2,417,000 | 1,544,000 | 3,387,000 |
| Other Investing Activity | -1,508,000 | -391,000 | 180,000 | 1,486,000 | 382,000 |
| Investing Cash Flow | $-20,825,000 | $-12,922,000 | $-8,103,000 | $-581,000 | $-6,194,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 3,391,000 | 3,335,000 | 2,717,000 | 10,000 | 39,000 |
| Debt Issued | 7,431,000 | 7,431,000 | 1,000 | 0 | 3,000 |
| Debt Repayment | -1,064,000 | -562,000 | -11,000 | -11,000 | -2,823,000 |
| Common Stock Issued | 1,114,000 | 922,000 | 708,000 | 332,000 | 954,000 |
| Common Stock Repurchased | -3,221,000 | -2,900,000 | -2,417,000 | -1,711,000 | -6,746,000 |
| Dividend Paid | -10,481,000 | -7,823,000 | -5,164,000 | -2,505,000 | -9,917,000 |
| Other Financing Activity | -3,290,000 | -879,000 | -506,000 | -430,000 | 475,000 |
| Financing Cash Flow | $-6,120,000 | $-476,000 | $-4,672,000 | $-4,315,000 | $-18,015,000 |
| Exchange Rate Effect | 89,000 | -135,000 | -166,000 | -237,000 | -9,000 |
| Beginning Cash Position | 17,305,000 | 17,305,000 | 17,305,000 | 17,305,000 | 18,107,000 |
| End Cash Position | 13,985,000 | 18,965,000 | 11,174,000 | 15,530,000 | 17,305,000 |
| Net Cash Flow | $-3,320,000 | $1,660,000 | $-6,131,000 | $-1,775,000 | $-802,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 23,536,000 | 15,193,000 | 6,810,000 | 3,358,000 | 23,416,000 |
| Capital Expenditure | -3,347,000 | -2,024,000 | -1,287,000 | -625,000 | -3,498,000 |
| Free Cash Flow | 20,189,000 | 13,169,000 | 5,523,000 | 2,733,000 | 19,918,000 |